CMS, Inc. and Toshiba Collaborate to Improve Cancer Treatment for St. Luke's Mountain States Tumor Institute of Idaho.

ST. LOUIS -- CMS, Inc., the worldwide market leader in radiation treatment planning and workflow management solutions, in partnership with Toshiba America Medical Systems, Inc., are providing a comprehensive diagnostic imaging and virtual simulation solution to St. Luke's Mountain States Tumor Institute (MSTI) in Boise, Idaho. The installation of CMS FocalSim and Toshiba's Aquilion[TM] LB computed tomography (CT) scanner represents the first joint installation to result from an earlier announced partnership between CMS and Toshiba.

St. Luke's MSTI will add CMS's FocalSim CT simulation workstation - a flexible PC-based application that includes multi-modality image fusion, patient contouring, CT simulation and plan review modules -- along with CMS Direct Access, a unique distributed workflow management tool that supports robust remote access to CMS planning applications from any location inside or outside the clinic. In addition, the facility will have Toshiba's Aquilion LB computed tomography (CT) scanner, designed to deliver superior patient positioning with superior image quality and clinical performance.

St. Luke's MSTI is one of the American Northwest's most respected cancer care centers with true dedication to the study, prevention and treatment of cancer. "Great strides have been made in treating and curing cancer, and St. Luke's MSTI is expanding as rapidly as today's cancer treatment options," said Eric A. Smith, Radiation Oncology Manager of St. Luke's MSTI. "New innovations by CMS and Toshiba are providing more effective and easier methods of radiation planning for our staff, which leads to successful outcomes for our patients."

"Our partnership with Toshiba creates greater efficiencies and clinical benefits for St. Luke's and their patients," said Andy Cowen, President and Chief Executive Officer of CMS. "St. Luke's is the first cancer treatment center to adopt FocalSim along with Toshiba's 'state-of-the-art' CT scanner. With the pending launch of Monaco, our next-generation specialized IMRT planning solution, as well as the upcoming release of our new Focal 4D tools, we look forward to providing innovative planning capabilities and flexible, vendor-independent solutions that enhance our customers' workflow and improve patient care."

The Focal product line from CMS is an integrated suite of innovative software tools that addresses key elements of radiotherapy clinical workflow. Focal is a Windows-based distributed planning platform that includes advanced contouring, simulation, image fusion and plan review capabilities, and combines an intuitive user interface with powerful but easy-to-use automation tools to increase overall planning efficiency and streamline clinical workflow. Focal is fully DICOM compliant and interconnects seamlessly with CMS's XiO and Monaco planning solutions along with other third-party planning systems.

With CMS Direct Access, users can access CMS planning tools securely from any networked PC via a high-speed Internet connection, increasing resource flexibility and productivity. CMS Direct Access also supports remote and distributed planning models, facilitating the sharing of resources and expertise inside the hospital and across regional networks.

CMS is a worldwide leader in the development and support of radiation treatment planning and workflow management solutions. With treatment planning systems installed in more than 1,500 sites worldwide, CMS is a global resource to the radiation oncology community. A privately held corporation, CMS employs 285 professionals in its headquarters located in St. Louis, MO and regional offices in Tampa, Florida; Freiburg, Germany; Tokyo, Japan; Sydney, Australia; and Shanghai, China.

Forward-Looking Statements

Statements contained in this release, which are not historical facts, may be considered "forward-looking statements" under the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on current expectations and the current economic environment.

We caution the reader that such forward-looking statements are not guarantees of future performance. Unknown risk, uncertainties as well as other uncontrollable or unknown factors could cause actual results to materially differ from the results, performance or expectations expressed or implied by such forward-looking statements.